Professor Xiaojun Huang ‘s Team Reveals New Mechanism of Injury to Bone Marrow Endothelial Progenitor Cells and Proposes Targeted Repair Strategies
🩸 Professor Xiaojun Huang and Team: Illuminating Hope in Blood Health Meet the unsung heroes—Professor Xiaojun Huang and their dedicated team—who've ventured into the labyrinth of blood health, uncovering a profound truth within our marrow's tapestry. They've unraveled a poignant narrative—a disruption in glycolysis, a hidden force causing turmoil for endothelial progenitor cells (EPCs). This upheaval imperils the delicate dance of hematopoiesis, the heartbeat of our blood's resilience. Backed by national R&D programs and the unwavering support of the National Natural Science Foundation, their discovery isn't just science; it's a lifeline for those navigating the storm of chemotherapy, radiotherapy, and stem cell transplants. Picture the impact—precision treatments targeting this anomaly, preserving the marrow's sanctity amid the chaos of treatments, kindling hope for countless souls. Their tale echoed at prestigious gatherings—the 24th European Hematology Association Congress (EHA) and the 48th European Society for Blood and Marrow Transplantation Congress (EBMT)—etched in Haematologica journal's pages.